Introduction
• Human Immunode ency Virus (HIV) is the cause of Acquired Immune De ciency Syndrome (AIDS) 1 • There are over 35 million people living with the virus globally 2 • Highly active antiretroviral therapy (HAART) is used in the management of HIV infection
• HAART is intended to achieve virological control, enhance diminished immune function, limit the development of resistant strains of the virus, and reduce the risk of transmission [3] [4] [5] [6] [7] • HAART is lifelong but, unlike other chronic diseases, successful management of HIV infection requires at least 95% adherence [8] [9] [10] [11] • Currently, more than 7.3 million infected people have access to medication but adherence is sub-optimal in many settings [12] [13] [14] [15] [16] [17] • Patient-related factors are the chief factors a ecting adherence 18 • Other factors are related to therapy, health system, condition, or socioeconomic status 19 • Sampling was non-random -However, data collection was designed to reach all patients over the course of one month • No signi cant di erences in demographic and clinical factors between patients who were 100% adherent vs. <100% adherent (Table 2) • Satisfaction with therapy -84.8% were satis ed or very satis ed -Mean±SD = 4.1±0.8
• Study design -Cross-sectional study using a survey-based instrument
• Study period -June-July 2012
• Study site -An HIV clinic in a tertiary university teaching hospital in Lagos, Nigeria • Serve ~6,000 patients who visit the clinic monthly • HAART medications were provided free-of-charge 
METHOD 2
Formula:
7-item scale scored (Yes=0 points; No=1 point) and summed
Fully adherent (7 points) Not Fully adherent (<7 points)
Modi ed Morisky scale (Table 1) • Adherence rates were significantly correlated (r=0.476, p<0.001), but differed by ~30 percentage points
• Multivariate logistic regression analysis of patient-related factors associated with 100% adherence (using Method 1) was signi cant -Likelihood ratio χ 2 =57.16, p<0.001 -Number of barriers was significantly related OR=0.39;95% CI=0.30-0.52
• For every unit increase in the number of barriers, patients were 60.8% less likely to be 100% adherent
• The di erence in adherence rates using the 2 methods can potentially be explained by the variation in recall period -Method 1 • Full adherence (100%) rate was 79.5%
• Recall period was 2 weeks -Method 2 • Full adherence (score=7) was 49.6%
• Recall period ranged from past day to 2 weeks to non-specific time frames (Table 1) • Overall adherence was optimal -Availability of medications free-of-charge may have facilitated full adherence
• Number of barriers was positively associated with adherence -Top barriers: forgetting, running out of medication, abstaining from alcohol, experiencing side e ects
• Strategies to address top barriers -Help patients build organizational skills (e.g., automated reminders, daily cues) -Emphasize the importance of lifelong adherence -Schedule more frequent clinic appointments or follow-up with phone calls or text messaging -Investigate whether cost of transportation or clinic hours are the issue since medications were free -Provide other alternatives for stress relief (exercise, meditation, prayer) to replace alcohol consumption -Intervene early to address medication side e ects and o er alternatives
